Phase II study of ceralasertib (ATR inhibitor) plus durvalumab in patients with advanced gastric cancer (AGC) who progressed on prior anti-PD-(L)1 therapy

Citations

WEB OF SCIENCE

0
제목
Phase II study of ceralasertib (ATR inhibitor) plus durvalumab in patients with advanced gastric cancer (AGC) who progressed on prior anti-PD-(L)1 therapy
저자
Lim, Sung HeeAn, MinaeShin, Ji EunKwon, MinsukKim, Seung TaeLee, Jeeyun
DOI
10.1200/JCO.2026.44.16_suppl.4062
발행일
2026-06-01
유형
Meeting Abstract
저널명
Journal of Clinical Oncology
44
16_SUPPL